NCT01911455View on ClinicalTrials.gov

Study of Acamprosate in Fragile x Syndrome

PHASE1CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

August 27, 2013

Primary Completion Date

November 8, 2018

Study Completion Date

November 8, 2018

Conditions
Fragile X Syndrome
Interventions
DRUG

acamprosate

DRUG

Placebo

Trial Locations (2)

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

60612

Rush University Medical Center, Chicago

All Listed Sponsors
collaborator

Rush University Medical Center

OTHER

lead

Children's Hospital Medical Center, Cincinnati

OTHER

NCT01911455 - Study of Acamprosate in Fragile x Syndrome | Biotech Hunter | Biotech Hunter